Generic Name: Denosumab
Brand Name: XGEVA
Manufacturer: Amgen Canada Inc.
Therapeutic Area: Prevention of skeletal-related events due to bone metastases from solid tumours
Indications: Prevention of skeletal-related events due to bone metastases from solid tumours
Submission Type: Initial
Project Status: Complete
Date Recommendation Issued: November 16, 2011
Recommendation Type: List with clinical criteria and/or conditions